08329 NEP INTERLONG
- 0.140
- +0.001+0.72%
NEP INTERLONG News
NEP INTERLONG: 2024 INTERIM REPORT
NEP INTERLONG: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Nep Interlong (08329): Shenzhen Neptunus Bioengineering plans to change its equity structure.
NEP Interlong (08329) announced that the company has obtained a strategic investment from Shenzhen Neptunus Bioengineering Co., Ltd. (Neptunus Bioengineering)...
Neptune Interlon (08329) announced its first quarter results. Profit attributable to shareholders of 19.3 million yuan increased 18.67% year over year
Neptune Interlon (08329) announced the first quarter results for the three months ended March 31, 2024. The group took...
NEP INTERLONG: ABSTRACT OF THE FIRST QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2024
Neptune Interlon (08329.HK) will purchase medical devices from the Neptune Group
Gelonghui, May 7, 丨 Neptune Interlon (08329.HK) announced that the company and Neptune Biotech (the company's controlling shareholder and related party) entered into a 2024 framework agreement on May 7, 2024. Based on this, the Group will purchase medical devices from Haiwang Group to be sold on behalf of China.
NEP INTERLONG: 2023 Annual Report
Neptune Interlon (08329) announced 2023 results. Profit attributable to owners of 24.127 million yuan decreased by 55.6% year-on-year
Neptune Interlon (08329) announced its 2023 results, with revenue of about 1,065 billion yuan, an increase of about 7.9 billion yuan over the previous year...
NEP INTERLONG: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
NEP INTERLONG: POSTPONEMENT OF DATE OF BOARD MEETING
Neptune Interlon (08329) Fa Profit Alert expects annual profit attributable to shareholders to be reduced by more than 50%
According to the Zhitong Finance App, Neptune Interlon (08329) announced that it is expected that the profit attributable to company owners obtained by the Group for the year ended December 31, 2023 will be reduced by more than 50% compared to the same period in 2022. The main reason for this reduction was due to impairment losses in goodwill formed when the Group acquired Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
NEP INTERLONG: INSIDE INFORMATION ANNOUNCEMENTPROFIT WARNING
Neptune Interlon (08329) and Neptune Easy Pharmaceutical signed a distribution agreement for 2023
According to the Zhitong Finance App, Neptune Interlon (08329) issued an announcement regarding the 2020 Neptune Star Consignment Agreement. Since the 2020 Neptune Star Consignment Agreement will expire on December 31, 2023, on December 28, 2023, the company and Neptune (a related party of the company) signed a 2023 consignment agreement. The Group will supply pharmaceuticals, food, health food and medical equipment to Easy Pharmaceutical Group for consignment sales in China. According to reports, these drugs (mainly including antibiotics, psychosomatic drugs, respiratory drugs, anti-allergy drugs and digestive drugs) and medical equipment are managed by the Group
NEP INTERLONG: THIRD QUARTERLY REPORT 2023
Neptune Intron (08329) announced the first three quarter results, profit attributable to owners of 45.56 million yuan, up 26.81% year on year
According to the Zhitong Finance App, Haiwang Intron (08329) announced its results for the first three quarters of 2023, with revenue of approximately RMB 823 million, up 19.41% year on year; profit attributable to company owners of RMB 45.06 million, up 26.81% year on year; earnings per share of 2.71 points.
NEP INTERLONG: ANNOUNCEMENT OF THIRD QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
NEP INTERLONG: 2023 INTERIM REPORT
NEP INTERLONG: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Haiwang Interlong (08329): Shen Dakai retires as non-executive director
According to the Zhitong Finance App, Haiwang Interlong (08329) issued an announcement that Zhang Xiaoguang has been appointed as an executive director, effective from June 25, 2023. Furthermore, due to the work schedule, Shen Dakai did not seek re-election at the company's annual shareholders' meeting, so Shen Dakai's term of office will expire on June 24, 2023, and will retire as a non-executive director thereafter.
Haiwang Intelong (08329) appoints Zhang Xiaoguang as Executive Director
According to the Zhitong Finance App, Haiwang Interlong (08329) issued an announcement with effect from June 25, 2023: re-election of Zhang Feng and Huang Jianbo as executive directors, re-election of Zhang Yifei, Yu Lin and Jin Rui as non-executive directors, and re-election of Yi Yongfa, Pan Jiayang and Zhang Jianzhou as independent non-executive directors. Zhang Xiaoguang was appointed as Executive Director. Xiong Chuxiong and Jin Ge were re-elected as supervisors and Cao Yang was re-elected as employee representative supervisor. Zhang Feng has been elected chairman of the new board of directors for a term of 3 years. Xiong Chuxiong has been elected chairman by the new board of supervisors for a term of 3 years.
Analysis
Price Target
No Data
No Data